Page last updated: 2024-08-26

bosentan anhydrous and Hyperparathyroidism

bosentan anhydrous has been researched along with Hyperparathyroidism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burgos, ME; Felsenfeld, AJ; Jara, A; Jara, X; Mezzano, S; Valdivieso, A; von Höveling, A1
Fujimura, S; Iwashita, K; Kanesaka, Y; Naomi, S; Tokunaga, H; Tomita, K1

Other Studies

2 other study(ies) available for bosentan anhydrous and Hyperparathyroidism

ArticleYear
Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:4

    Topics: Animals; Antihypertensive Agents; Bosentan; Cell Proliferation; Endothelin Receptor Antagonists; Hyperparathyroidism; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus, Dietary; Rats; Rats, Sprague-Dawley; Sulfonamides; Uremia

2006
Endothelin receptor antagonist prevents parathyroid cell proliferation of low calcium diet-induced hyperparathyroidism in rats.
    Endocrinology, 2001, Volume: 142, Issue:1

    Topics: Animals; Bosentan; Calcium; Calcium, Dietary; Cell Division; Endothelin Receptor Antagonists; Endothelin-1; Hyperparathyroidism; Male; Parathyroid Glands; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors

2001